research platform

AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. They have developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data.

AllStripes is a a Public Benefit Corporation and was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and a number of angel investors.

"As the leading research platform dedicated to rare diseases, AllStripes makes it easy for patients to contribute to new treatment research from home. We do the work to collect and analyze de-identified medical records to help power faster, better drug development. We partner with rare disease patient advocacy organizations and key opinion leaders to build our programs. Our expert researchers produce original research insights and publications, as well as partner with academic institutions and pharmaceutical companies to make progress towards new treatments."

Also see: Care Access